1 ANASTROZOLE | 420 of 940 | 700 prescriptions Less than 1% of all prescriptions | | 230 patients 13% of all patients | < 11 | |
2 PREDNISONE | 20 of 820 | 1240 prescriptions Less than 1% of all prescriptions | | 340 patients 20% of all patients | < 11 | |
3 ZYTIGA (ABIRATERONE ACETATE) | 50 of 370 | 620 prescriptions Less than 1% of all prescriptions | 620 | < 11 | < 11 | |
4 LIDOCAINE-PRILOCAINE (LIDOCAINE/PRILOCAINE) | 90 of 420 | 250 prescriptions Less than 1% of all prescriptions | | 230 patients 13% of all patients | < 11 | |
5 HYDROXYUREA | 370 of 820 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
6 GABAPENTIN | 280 of 760 | 230 prescriptions Less than 1% of all prescriptions | | 110 patients 6% of all patients | < 11 | |
7 XARELTO (RIVAROXABAN) | 340 of 690 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
8 OXYCODONE HCL | 90 of 700 | 480 prescriptions Less than 1% of all prescriptions | | 240 patients 14% of all patients | < 11 | O |
9 CABOMETYX (CABOZANTINIB S-MALATE) | 30 of 60 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
10 PROCHLORPERAZINE MALEATE | 40 of 820 | 640 prescriptions Less than 1% of all prescriptions | | 510 patients 30% of all patients | < 11 | |
11 BICALUTAMIDE | 80 of 250 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
12 XTANDI (ENZALUTAMIDE) | 120 of 270 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
13 ONDANSETRON ODT (ONDANSETRON) | 20 of 410 | 590 prescriptions Less than 1% of all prescriptions | | 440 patients 26% of all patients | < 11 | |
14 LORAZEPAM | 310 of 650 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 DEXAMETHASONE | 450 of 940 | 180 prescriptions Less than 1% of all prescriptions | 180 | 120 patients 7% of all patients | 120 patients 7% of all patients | |
16 TRAMADOL HCL | 150 of 370 | 170 prescriptions Less than 1% of all prescriptions | 170 | 140 patients 8% of all patients | 140 patients 8% of all patients | O |